The FDA’s Antimicrobial Drugs Advisory Committee voted 13 to 10 to recommend emergency authorization of molnupiravir, an oral antiviral drug to fight Covid.
Read more: cnbc.com
Related Posts
Get your custom MOON reading
Home Plan-Demic FDA advisory panel narrowly endorses Merck’s oral Covid treatment pill, despite reduced...
